A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Actos (pioglitazone): Ongoing Safety Review – Potential Increased Risk of Bladder Cancer. According to the Food & Drug Administration FDA’s MedWatch:
UPDATED 06/15/2011. Risk information updated in labels, pioglitazone should not be used in patients with active bladder cancer.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Actos (pioglitazone): Ongoing Safety Review – Potential Increased Risk of Bladder Cancer.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.